Sign inJoin waitlistJoin the waitlist

Sonali Chaudhury

Section Head, Stem Cell Transplantation and Cellular Therapies · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

Stem Cell Transplantation and Cellular Therapies Section · McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

McGaw Medical Center of Northwestern University
2006–2007
Memorial Sloan Kettering Cancer Center
2003–2006
New York Presbyterian Hospital
2005–2006
Internal Medicine
New York Presbyterian Hospital
2000–2003
Pediatrics
New York Presbyterian Hospital
2002–2003
B J MED COLL, GUJARAT UNIV, AHMEDABAD, GUJARAT
1989–1993

Research

Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients
Biology of Blood and Marrow Transplantation · 2014 · Last of 12 authors · 180 citations
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A…
Transplantation and Cellular Therapy · 2021 · 172 citations
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Blood · 2016 · 169 citations

Michael Pulsipher
23 papers
SS
Shalini Shenoy
23 papers
Christopher Dvorak
15 papers
David Jacobsohn
15 papers
Monica Bhatia
15 papers
KK
Kim Kasow
14 papers
Susan Prockop
14 papers
Jennifer Schneiderman
13 papers
Lolie Yu
12 papers
Morris Kletzel
12 papers
RD
Reggie Duerst
11 papers
WT
William Tse
11 papers

Clinical trials

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 2
Children's Oncology Group
2019–2026
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Principal investigator · Unknown · Phase 1, Phase 2
Ann & Robert H Lurie Children's Hospital of Chicago
2008–2015
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Principal investigator · Completed · Phase 2, Phase 3
Gamida Cell -Teva Joint Venture Ltd.
2007–2015
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
Principal investigator · Completed
Ann & Robert H Lurie Children's Hospital of Chicago
2007–2019